Secure Your Family's Skin Health - Melanoma Genetic Risk Assessment (CDKN2A/CDK4)

An advanced laboratory test screening for CDKN2A and CDK4 mutations associated with hereditary melanoma. It assesses genetic predisposition, helping clinicians develop personalized surveillance and preventive monitoring plans.